By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Proceedings of the National Academy of Sciences (PNAS) 

Editorial Office
2101 Constitution Ave N.W.
Washington  D.C.  FO2013  U.S.A.
Phone: 202-334-2672 Fax: 202-334-2739




Company News
Syntimmune Announces Breakthrough Results Of FcRn Inhibition Published In PNAS 3/21/2017 7:03:37 AM
SignalRX Pharmaceuticals Announces Breakthrough Results On Novel Anti-Cancer Dual PI3K-BRD4 Inhibition Paradigm In PNAS Publication 2/1/2017 8:02:18 AM
Ritter Pharmaceuticals, Inc. Phase 2a Lactose Intolerance Clinical Trial Microbiome Data, Published In PNAS 1/4/2017 10:27:47 AM
F2G Announces Publication Of Initial F901318 Data In Scientific Journal PNAS 10/26/2016 7:43:11 AM
Kid-Friendly Medical Devices Bring Calmer Patients, Study Published In PNAS 7/28/2016 8:09:52 AM
Impatient People May Age Faster, Study Published In PNAS 2/24/2016 7:00:55 AM
Antibiotics May Up Risk Of STDs, Study Published In PNAS 2/4/2016 7:02:30 AM
Biscayne Pharmaceuticals Release: New Study Published In PNAS Shows Biscayne's GHRH Agonists Could Increase The Feasiblity Of Beta Cell Transplants To Treat Type 1 Diabetes 10/20/2015 8:26:57 AM
Humabs Biomed Release: PNAS Paper Details Efficacy Of A Potent, Fully Human Antibody For The Treatment Of MERS 7/28/2015 9:22:34 AM
Momenta Pharmaceuticals, Inc. (MNTA) Announces Publication Revealing Development Of A Novel Process To Generate High-Quality Hyper-Sialylated IVIg Drug Candidate In PNAS 3/3/2015 7:15:19 AM